Viva Biotech (1873.HK) Announces 2023 Annual Results: Succes

HONG KONG, March 28, 2024 /PRNewswire/ --

Highlights of the Annual Results as of December 31, 2023:
Revenue reached RMB2,155.6 millionGross profit amounted to RMB738.5 millionAdjusted non-IFRS net...

Related Keywords

Australia , Chengdu , Sichuan , China , Zhejiang , Switzerland , Germany , Dubai , Dubayy , United Arab Emirates , Taiwan , France , Jiaxing , Shanghai , Taizhou , Jiangsu , United Kingdom , United States , Qiantang , Guangdong , Canada , Hangzhou , Japan , Zhoupu , Suzhou , Chinese , America , Chen Cheney Mao , Langhua Pharma , Ningbo Nuobai , Viva Biotech Holdings Group , Langhua Pharmaceuticals , Successful Exits Of Certain Incubation Portfolio Companies , Temasek , Viva Biotech Holdings , Shanghai Supercomputing Center , Investment Corporation Of Dubai , Annual Results , Highlight Capital , True Light Capital , Investment Corporation , Reporting Period , Attractive Outlook , Long Run Despite Slight Fluctuation , Chinese Mainland , Langhua Pharmaceutical , Certain Incubation Portfolio Companies , Future Plans , Incubation Business , North America , Active Pharmaceutical Ingredient , Shanghai Supercomputing , Faladi Road , Qiantang New District , Supercomputing Center , Viva Biotech , Markets ,